Reyataz label
Interaction Color Code
Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits of using this combination
Drug 1
Drug 1 dose
300 mg with 100 mg ritonavir daily
Drug 1 effect
Not reported
Drug 2
Drug 2 dose
250 mg with 100 mg proguanil x 1
Drug 2 effect
Atovaquone AUC decreased 46%, Cmax decreased 49%
Clinical Effects
Potential compromised antimalarial activity
Management
Dose adjustment not established. If coadministering monitor for anti-malarial efficacy.
Import ID
851
